Key Points
In a major crackdown against the manufacture of substandard drugs, central and state regulators conducted joint inspections at 76 pharma companies and cancelled the licences of 18 of them for producing spurious and adulterated drugs, official sources said on Tuesday...
A source said that the action has been taken against 76 companies in the first phase of a special drive against the manufacture of substandard drugs...
Licences of 18 pharma companies have been cancelled for manufacturing spurious and adulterated drugs and for violating GMP (good manufacturing practice)..
A majority of the companies are from Himachal Pradesh (70), followed by Uttarakhand (45) and Madhya Pradesh (23).. Recently, questions have been raised over the quality of drugs manufactured by India-based companies..
You might be interested in
Licences of 18 pharma firms cancelled for manufacturing spurious drugs
28, Mar, 23In a major crackdown, license of 18 pharma companies have been cancelled for manufacturing of spurious medicines
Drug licences of 18 pharma firms cancelled for manufacturing poor quality medicines
28, Mar, 23Decision came following inspection by state and central regulators
DGCI cancels licences of 18 pharma firms on allegations of spurious drugs
13, Apr, 23About 76 pharma companies were inspected across 20 states and union territories, with around 203 firms identified for review.